Webinar: Pandemic Vaccine Development and Lessons for COVID-19

On Thursday, April 2, AVAC held it second webinar on COVID-19 and its relationship to HIV. Dr. Mark Feinberg, CEO of IAVI, shared experiences and lessons from Ebola and HIV vaccine development that might be applied to COVID-19 vaccine development. Dr. Feinberg was joined by Dr. Helen Rees of Wits RHI to discuss the history and role of the Coalition for Epidemic Preparedness Innovations (CEPI), which supports vaccine development against emerging infectious diseases, including COVID-19.

Listen

• Listen to the full recording (1:05:09)

Excerpts

• Mark Feinberg explores lessons from vaccine development in HIV and Ebola and relevance to COVID-19 (20:58)
• Helen Rees discusses the Coalition of Epidemic Preparedness Innovations & the status of research for therapy for COVID-19 (11:48)
• Q&A: The science of partnership — A discussion about the vaccine development process and global coordination (6:41)
• Q&A: Why investment must be made now to deliver a COVID-19 vaccine at scale (8:50)
• Q&A: Helen Rees talks about the Solidarity study testing therapy for COVID-19 (5:11)
• Q&A: A discussion of mutation in the COVID-19 virus and how to sustain capacity to respond to epidemics (5:13)
• Q&A: Global health reframed, cooperation, openness & equity for both COVID-19 and HIV response (5:07)

Transcript

• Download the webinar transcript